Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share (NVCT)

CUSIP: 67080T108

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+543,149
Put/Call ratio
79%
SEC-reported price per share
$7.55
Number of holders
47
Value change
+$4,308,822
Number of buys
28
Open additional details 1 more signal available
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
32,314,196

Security key

67080T108

Report period

Q4 2025

Institutions

47

Top holders

10

Ownership snapshot

Top reported holders of NVCT - Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Sep 2025
13F 3/4/5 Highest disclosed value: $4,206,222 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $4.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $4.21M
BlackRock, Inc. $4.13M
IRIDIAN ASSET MANAGEMENT LLC/CT $2.44M
BALDWIN WEALTH PARTNERS LLC/MA $2.11M
GEODE CAPITAL MANAGEMENT, LLC $1.96M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$4,206,222
698,708 shares
— 30 Sep 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$4,125,728
685,337 shares
— 30 Sep 2025
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
13F
—
denominator unverified
$2,441,838
405,621 shares
— 30 Sep 2025
BALDWIN WEALTH PARTNERS LLC/MA
13F
Company
13F
—
denominator unverified
$2,109,775
350,461 shares
— 30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,961,379
325,733 shares
— 30 Sep 2025
Occam Crest Management LP
13F
Company
13F
—
denominator unverified
$1,745,800
290,000 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
47
Shares
4,238,693
Rows available
47
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
52
Q4 2025 holders
47
Holder diff
-5
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .